Barclays’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Buy |
394,041
+199,269
| +102% | +$2.79M | ﹤0.01% | 1547 |
|
|
2025
Q1 | $3.05M | Sell |
194,772
-43,169
| -18% | -$675K | ﹤0.01% | 1752 |
|
|
2024
Q4 | $3.31M | Sell |
237,941
-15,451
| -6% | -$215K | ﹤0.01% | 1885 |
|
|
2024
Q3 | $2.36M | Buy |
253,392
+151,279
| +148% | +$1.41M | ﹤0.01% | 2061 |
|
|
2024
Q2 | $949K | Buy |
102,113
+3,608
| +4% | +$33.5K | ﹤0.01% | 2144 |
|
|
2024
Q1 | $976K | Sell |
98,505
-10,155
| -9% | -$101K | ﹤0.01% | 2427 |
|
|
2023
Q4 | $351K | Sell |
108,660
-98,417
| -48% | -$318K | ﹤0.01% | 3212 |
|
|
2023
Q3 | $1.1M | Sell |
207,077
-26,341
| -11% | -$140K | ﹤0.01% | 2026 |
|
|
2023
Q2 | $2.22M | Sell |
233,418
-1,096,647
| -82% | -$10.4M | ﹤0.01% | 1676 |
|
|
2023
Q1 | $14.6M | Buy |
1,330,065
+149,681
| +13% | +$1.65M | 0.01% | 688 |
|
|
2022
Q4 | $17.5M | Buy |
1,180,384
+1,039,547
| +738% | +$15.4M | 0.01% | 681 |
|
|
2022
Q3 | $2.69M | Buy |
140,837
+106,001
| +304% | +$2.03M | ﹤0.01% | 1456 |
|
|
2022
Q2 | $742K | Sell |
34,836
-3,102
| -8% | -$66.1K | ﹤0.01% | 2276 |
|
|
2022
Q1 | $730K | Buy |
+37,938
| New | +$730K | ﹤0.01% | 2539 |
|